Veradigm (Veradigm) EBIT

: $131 Mil (TTM As of Sep. 2022)

View and export this data going back to 1999. Start your Free Trial

Veradigm's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2022 was $26 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2022 was $131 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Veradigm's annualized ROC % for the quarter that ended in Sep. 2022 was 3.98%. Veradigm's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was 225.83%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Veradigm's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was 23.67%.

Veradigm EBIT Historical Data

The historical data trend for Veradigm's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veradigm Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

EBIT

Get a 7-Day Free Trial

-152.50

-11.29

-238.58

-115.21

174.99

Veradigm Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EBIT	Get a 7-Day Free Trial															31.08	102.10	6.19	-3.43	26.04

Competitive Comparison

For the Health Information Services subindustry, Veradigm's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veradigm EV-to-EBIT Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Veradigm's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Veradigm's EV-to-EBIT falls into.

Veradigm EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $131 Mil.

Veradigm (OTCPK:MDRX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Veradigm's annualized ROC % for the quarter that ended in Sep. 2022 is calculated as:

	ROC % (Q: Sep. 2022 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2022 )	+	Invested Capital (Q: Sep. 2022 ))	/ count )
=	100.004 * ( 1 - 55.94% )	/	( (1113.074	+	1102.536)	/ 2 )
=	44.0617624	/	1107.805
=	3.98 %

where

	Invested Capital		(Q: Jun. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1714.216	-	100.978	-	( 500.164	-	max(0, 256.328	-	828.767	+	500.164	))
=	1113.074

	Invested Capital		(Q: Sep. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1690.659	-	95.526	-	( 492.597	-	max(0, 253.091	-	810.77	+	492.597	))
=	1102.536

Note: The Operating Income data used here is four times the quarterly (Sep. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Veradigm's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2022 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2022		Q: Sep. 2022
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	104.156	/	( ( (30.875 + max(29.341, 0))	+	(26.233 + max(5.795, 0)) )	/	2 )
=	104.156	/	( ( 60.216	+	32.028 )	/	2 )
=	104.156	/	46.122
=	225.83 %

where Working Capital is:

	Working Capital		(Q: Jun. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(166.746	+	0	+	112.828)	-	(100.978	+	84.882	+	64.373)
=	29.341

	Working Capital		(Q: Sep. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(169.029	+	0	+	83.691)	-	(95.526	+	98.93	+	52.469)
=	5.795

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Veradigm's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2022 )
	=	130.895	/	552.885
	=	23.67 %

Veradigm EBIT Related Terms

Thank you for viewing the detailed overview of Veradigm's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Veradigm (Veradigm) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veradigm Inc (OTCPK:MDRX) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654

Website

https://www.veradigm.com

Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

Executives

Shih Yin Ho	director	222 MERCHANDISE MART, SUITE 2024, CHICAGO IL 60654
Susan Rodriguez	director	C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555
Richard J. Poulton	officer: CFO	3646 WESTFIELD LANE, GLENVIEW IL 60026
Tejal Vakharia	officer: SVP Gerneral Counsel	222 MERCHANDISE MART PLZ, SUITE 2024, CHICAGO IL 60654
David B Stevens	director	1 IMATION WAY, OAKDALE MN 55128
Leah Jones	officer: Chief Financial Officer	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Paul Black	director	400 WOOD ROAD, BRAINTREE MA 02184
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Thomas Langan	officer: President and CCO	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Lisa Hammond	officer: SVP & Chief HR Officer	305 CHURCH AT NORTH HILLS STREET, RALEIGH NC 27609
Greg Garrison	director	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Lisa Khorey	officer: Chief Client Delivery Officer	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Michael Klayko	director
Carol J Zierhoffer	director	100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Brian Farley	officer: SVP Gerneral Counsel & Corpora	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654